
|Articles|November 1, 2002
Supplements and Featured Publications
- Use of Selective COX-2 Inhibitors for Chronic Therapy: The Managed Care Perspective
- Volume 8
- Issue 17 Suppl
Gastrointestinal Outcomes: Evidence for Risk Reduction in Patients Using Coxibs
Author(s)James M. Scheiman, MD
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA to Remove Black Box Warnings From HRT, Debate Ensues
2
Five Ways AI Is Transforming Cancer Care—and Companies That Are Making It Happen
3
Total Neoadjuvant Therapy May Aid Organ Preservation in Early Rectal Cancer
4
POLY-HF: Polypill Boosts Heart Function, Adherence in Heart Failure
5















































